{{Rsnum
|rsid=574808
|Gene=LOC730109
|Chromosome=3
|position=160015196
|Orientation=plus
|GMAF=0.3563
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL12A-AS1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.3 | 52.7 | 33.0
| HCB | 5.8 | 28.5 | 65.7
| JPT | 2.7 | 26.5 | 70.8
| YRI | 15.6 | 43.5 | 40.8
| ASW | 28.1 | 38.6 | 33.3
| CHB | 5.8 | 28.5 | 65.7
| CHD | 5.6 | 38.0 | 56.5
| GIH | 4.0 | 34.7 | 61.4
| LWK | 23.1 | 49.1 | 27.8
| MEX | 19.0 | 50.0 | 31.0
| MKK | 3.2 | 34.2 | 62.6
| TSI | 13.7 | 39.2 | 47.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19458352
|Title=Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
|OA=1
}}

{{PharmGKB
|RSID=rs574808
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19458352
|Annotation=A GWAS of 2072 Canadian and U.S. subjects (536 patients with primary biliary cirrhosis and 1536 controls) showed that primary biliary cirrhosis was significantly and reproducibly associated with this SNP (rs574808) at the IL12A locus (P=1.88x10(-13); odds ratio, 1.54).
|Drugs=
|Drug Classes=
|Diseases=Liver Cirrhosis, Biliary
|Curation Level=Curated
|PharmGKB Accession ID=PA164918145
}}

{{omim
|id=109720
|rsnum=574808
}}

{{PMID|21506939}} Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs574808
|overall_frequency_n=49
|overall_frequency_d=124
|overall_frequency=0.395161
|n_genomes=33
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}